Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
The effect of tranexamic acid versus placebo in patients undergoing noncardiac surgery - POISE-3 trial
FY 2016-17
Summary
Major perioperative cardiovascular complications and major perioperative bleeding represent important public health problems affecting over 10 million adults annually. Our perioperative ischemic evaluation (POISE) trial randomized 8351 patients in 190 centres in 23 countries and demonstrated that Metoprolol prevented myocardial infarction but increased risk of stroke and death. There is emerging evidence that perioperative bleeding and anemia are associated with significant vascular complications and risk of transfusion. Tranexamic acid is an antifibrinolytic agent that has demonstrated benefit in reducing blood loss in other settings, such as cardiac surgery and trauma. The objective of the POISE-3 trial is to look at the impact of tranexamic acid on 30-day major cardiovascular events, defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal cardiac arrest. This trial represents important public health problems affecting over 10 million adults annually. These interventions have the potential to help millions of patients annually and influence future perioperative practices around the world.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367383
Name
Yang Stephen S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The effect of tranexamic acid versus placebo in patients undergoing noncardiac surgery - POISE-3 trial
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiovascular Disease; Noncardiac Surgery; Perioperative Vascular Complications; Randomized Controlled Trial; Tranexamic Acid
Abstract
Major perioperative cardiovascular complications and major perioperative bleeding represent important public health problems affecting over 10 million adults annually. Our perioperative ischemic evaluation (POISE) trial randomized 8351 patients in 190 centres in 23 countries and demonstrated that Metoprolol prevented myocardial infarction but increased risk of stroke and death. There is emerging evidence that perioperative bleeding and anemia are associated with significant vascular complications and risk of transfusion. Tranexamic acid is an antifibrinolytic agent that has demonstrated benefit in reducing blood loss in other settings, such as cardiac surgery and trauma. The objective of the POISE-3 trial is to look at the impact of tranexamic acid on 30-day major cardiovascular events, defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal cardiac arrest. This trial represents important public health problems affecting over 10 million adults annually. These interventions have the potential to help millions of patients annually and influence future perioperative practices around the world.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yang, Stephen S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~